[CHRS] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
08-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -28.86%
YoY- -237.93%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 60,151 60,115 73,371 82,503 87,643 83,034 110,419 -33.37%
PBT -50,150 -96,084 -45,725 -38,528 -29,900 -172,947 10,760 -
Tax 6,137 15,159 5,793 5,801 5,758 5,709 1,052 225.10%
NP -56,287 -111,243 -45,725 -38,528 -29,900 -172,947 9,708 -
Tax Rate - - - - - - -9.78% -
Total Cost 116,438 171,358 119,096 121,031 117,543 255,981 100,711 10.18%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -93.58 -185.05 -62.32 -46.70 -34.12 -208.28 8.79 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.73 -1.44 -0.60 -0.49 -0.40 -2.37 0.13 -
EPS Diluted -0.73 -1.44 -0.60 -0.49 -0.40 -2.37 0.12 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.